+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Melanoma Market and Competitive Landscape - 2020

  • ID: 5023432
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Melanoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Melanoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Melanoma market size and drug sales. It also provides insights into Melanoma epidemiology and late stage pipeline.

This research covers the following: Melanoma treatment options, Melanoma late stage clinical trials pipeline, Melanoma prevalence by countries, Melanoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Melanoma pipeline: Find out drugs in clinical trials for the treatment of Melanoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Melanoma epidemiology: Find out the number of patients diagnosed (prevalence) with Melanoma by countries
  • Melanoma drugs: Identify key drugs marketed and prescribed for Melanoma in the US, including trade name, molecule name, and company
  • Melanoma drugs sales: Find out the sales value for Melanoma drugs by countries
  • Melanoma market valuations: Find out the market size for Melanoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Melanoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Melanoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Melanoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Melanoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Melanoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Melanoma Treatment Options

2. Melanoma Pipeline Insights
2.1. Melanoma Phase 3 Clinical Trials
2.2. Melanoma Phase 2 Clinical Trials
2.3. Melanoma Phase 1 Clinical Trials

3. Melanoma Epidemiology Analysis by Countries

4. Germany Melanoma Market Insights
4.1. Marketed Drugs for Melanoma in Germany
4.2. Germany Melanoma Market Size & Forecast
4.3. Germany Melanoma Drugs Sales Forecast
4.4. Germany Melanoma Market Share Analysis

5. France Melanoma Market Insights
5.1. Marketed Drugs for Melanoma in France
5.2. France Melanoma Market Size & Forecast
5.3. France Melanoma Product Sales Forecast
5.4. France Melanoma Market Share Analysis

6. Italy Melanoma Market Insights
6.1. Marketed Drugs for Melanoma in Italy
6.2. Italy Melanoma Market Size & Forecast
6.3. Italy Melanoma Product Sales Forecast
6.4. Italy Melanoma Market Share Analysis

7. Spain Melanoma Market Insights
7.1. Marketed Drugs for Melanoma in Spain
7.2. Spain Melanoma Market Size & Forecast
7.3. Spain Melanoma Product Sales Forecast
7.4. Spain Melanoma Market Share Analysis

8. UK Melanoma Market Insights
8.1. Marketed Drugs for Melanoma in UK
8.2. UK Melanoma Market Size & Forecast
8.3. UK Melanoma Product Sales Forecast
8.4. UK Melanoma Market Share Analysis

9. Europe Melanoma Market Insights
9.1. Europe Melanoma Market Size & Forecast
9.2. Europe Melanoma Product Sales Forecast
9.3. Europe Melanoma Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Melanoma Phase 3 Clinical Trials, Global, 2020
Table 2: Melanoma Phase 2 Clinical Trials, Global, 2020
Table 3: Melanoma Phase 1 Clinical Trials, Global, 2020
Table 4: Melanoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Melanoma in Germany, 2019
Table 6: Germany Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Melanoma Product Sales ($mn), 2016 - 2024
Table 8: Germany Melanoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Melanoma in France, 2019
Table 10: France Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Melanoma Product Sales ($mn), 2016 - 2024
Table 12: France Melanoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Melanoma in Italy, 2019
Table 14: Italy Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Melanoma Product Sales ($mn), 2016 - 2024
Table 16: Italy Melanoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Melanoma in Spain, 2019
Table 18: Spain Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Melanoma Product Sales ($mn), 2016 - 2024
Table 20: Spain Melanoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Melanoma in UK, 2019
Table 22: UK Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Melanoma Product Sales ($mn), 2016 - 2024
Table 24: UK Melanoma Market Events and Trends, 2016 - 2024
Table 25: Europe Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Melanoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Melanoma Pipeline by Phase (%), Global, 2020
Figure 2: Melanoma Prevalence by Countries, 2016 - 2024
Figure 3: Germany Melanoma Market Size ($mn), 2016 - 2024
Figure 4: Germany Melanoma Product Sales ($mn), 2016 - 2024
Figure 5: Germany Melanoma Market Share by Drugs (%), 2019
Figure 6: Germany Melanoma Market - Future Market Share (%), 2024
Figure 7: France Melanoma Market Size ($mn), 2016 - 2024
Figure 8: France Melanoma Product Sales ($mn), 2016 - 2024
Figure 9: France Melanoma Market Share by Drugs (%), 2019
Figure 10: France Melanoma Market - Future Market Share (%), 2024
Figure 11: Italy Melanoma Market Size ($mn), 2016 - 2024
Figure 12: Italy Melanoma Product Sales ($mn), 2016 - 2024
Figure 13: Italy Melanoma Market Share by Drugs (%), 2019
Figure 14: Italy Melanoma Market - Future Market Share (%), 2024
Figure 15: Spain Melanoma Market Size ($mn), 2016 - 2024
Figure 16: Spain Melanoma Product Sales ($mn), 2016 - 2024
Figure 17: Spain Melanoma Market Share by Drugs (%), 2019
Figure 18: Spain Melanoma Market - Future Market Share (%), 2024
Figure 19: UK Melanoma Market Size ($mn), 2016 - 2024
Figure 20: UK Melanoma Product Sales ($mn), 2016 - 2024
Figure 21: UK Melanoma Market Share by Drugs (%), 2019
Figure 22: UK Melanoma Market - Future Market Share (%), 2024
Figure 23: Europe Melanoma Market Size ($mn), 2016 - 2024
Figure 24: Europe Melanoma Product Sales ($mn), 2016 - 2024
Figure 25: Europe Melanoma Market Share by Drugs (%), 2019
Figure 26: Europe Melanoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll